Abstract
The biotechnological method of synthesis of ribavirin, vidarabin, and 6-azauridine by the use of immobilized recombinant enzymatic preparations of nucleoside phosphorylase was improved. The effect of ribavirin and its combinations with the other synthesized nucleosides on the reproduction of Vaccinia virus was studied on the culture of Vero cells. The combination of ribavirin and vidarabin was shown to provide the antiviral effect at lesser concentrations than with these compounds taken separately.
Similar content being viewed by others
REFERENCES
Eliot, G.B., Antiviral Chemotherapy: New Directions, Mills, I. and Corey, L., Eds. Amsterdam: Elsevier, 1986, pp. 118–137.
Roizman, B. and Sears, A., Virology, Field, H.J., Ed., New York: Lippincott-Raven, 1996, pp. 2231–2295.
Marques, V.E., in Phosphonylmethyl Ethers of Nucleo-sides and Their Acyclic Analogues as Antiviral Agents, Martin, J.C., Ed., Washington, DC: American Chemical Society, 1989, pp. 140–155.
Holy, A., Clercq, E., and Votruba, I., in Phosphonylme-thyl Ethers of Nucleosides and Their Acyclic Analogues as Antiviral Agents, Martin, J.C., Ed., Washington, DC: American Chemical Society, 1989, pp. 50–71.
Joklik, W.K., Jungwirth, C., Oda, K., and Woodson, B., in Molecular Biology of Viruses, Colter, J.C. and Paranchych, W., Eds., New York: Academic, 1969, pp.473–494.
Witkowski, J.T., Robins, R.K., Sidwell, R.W., and Simon, L.N., J.Med.Chem., 1972, vol. 15, pp. 1150–1154.
Reist, E.J., Benitez, A., Goodman, L., Baker, B.R., and Lee, W.W., J.Org.Chem., 1962, vol. 27, pp. 3274–3279.
Lukevits, E.Ya. and Zabolotskaya, A.E., Sillil'nyi metod sinteza nukleozidov (Silyl Method of Nucleoside Synthesis), Riga: Zinatne, 1985.
Prystas, M., Gut, J., and Sorm, F., Chem.Ind., 1961, pp.947–948.
Hennen, W.J. and Wong, C.H., J.Org.Chem., 1989, vol.54, pp. 4692–4695.
Bzowska, A., Kulikowska, E., and Shugar, D., Pharmacol.Therap., 2000, vol. 88, pp. 349–425.
Shirae, H., Yokozeki, K., and Kubota, K., Agric.Biol.Chem., 1988, vol. 52, pp. 295–296.
Krenitsky, T.A., Koszalka, G.W., Tuttle, J.V., Ride-out, J.L., and Eliot, G.B., Carbohydr.Res., 1981, vol. 97, pp. 139–146.
Hori, N., Watanabe, M., Sunagawa, K., Uehara, K., and Mikami, Y., J.Biotechnol., 1991, vol. 17, pp. 121–131.
Mikhailopulo, I.A., Zinchenko, A.I., Bokut, S.B., Dudchik, N.V., Barai, V.N., and Kalinichenko, E.N., Biotechnol.Lett., 1992, vol. 14, pp. 885–890.
Esipov, R.S., Gurevich, A.I., Chuvikovsky, D.V., Chupova, L.A., Muravyova, T.I., and Miroshnikov, A.I., Protein Express.Purif., 2002, vol. 24, pp. 56–60.
Esipov, R.S., Gurevich, A.I., Miroshnikov, A.I., and Chuvikovsky, D.V., Patent RF 2179188, 10.02.2002.
Esipov, R.S., Gurevich, A.I., Miroshnikov, A.I., and Chuvikovsky, D.V., Patent RF 2179998, 10.01.2002.560
Jurkiewicz, M., Alegret, S., and Fabregas, E., Anal.Chim.Acta, 1998, vol. 370, pp. 47–58.
Kito, M., Tawa, R., Takeshima, S., and Hirose, S., J.Chromatogr., 1990, vol. 528, pp. 91–99.
North, T.W. and Cohen, S.S., in International Encyclo-pedia of Pharmacology and Therapeutics: Viral Chemotherapy, Shugar, D., Ed., Oxford: Pergamon, 1984, pp.303–340.
Galegov, G.A., Florent'ev, V.L., L'vov, N.D., and Petrova, I.G., Vopr.Med.Khim., 1987, no. 1, pp. 40–51.
Toltzis, P., in Antiviral Chemotherapy.New Directions, Mills, I. and Corey, L., Eds., Amsterdam: Elsevier, 1986, pp. 75–78.
Sidwell, R.W., in Ribavirin.A Broad Spectrum Antiviral Agent, Smith, R.S., Ed., New York: Academic, 1981, pp.23–42.
Lowry, O.H., Rosebrough, N.I., Farr, A.L., and Randall, R.J., J.Biol.Chem., 1951, vol. 193, pp. 265–275.
Furukawa, Y. and Honjo, M., Chem.Pharm.Bull., 1968, vol. 16, pp. 2286–2288.
De Clerq, E., Descamps, J., Verheist, G., Walker, R.T., Jones, A.S., Torrence, P.F., and Shugar, D., J.Infect.Dis.,1980, vol. 141, pp. 563–573.
Field, H.J., Darby, G., and Wildy, P., J.Gen.Virol., 1980, vol. 49, pp. 115–124.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Konstantinova, I.D., Leont'eva, N.A., Galegov, G.A. et al. Ribavirin: Biotechnological Synthesis and Effect on the Reproduction of Vaccinia Virus. Russian Journal of Bioorganic Chemistry 30, 553–560 (2004). https://doi.org/10.1023/B:RUBI.0000049772.18675.34
Issue Date:
DOI: https://doi.org/10.1023/B:RUBI.0000049772.18675.34